共 50 条
Ambulatory Management of Worsening Heart Failure: Current Strategies and Future Directions
被引:4
|作者:
Wand, Alison L.
[1
]
Russell, Stuart D.
[2
]
Gilotra, Nisha A.
[1
]
机构:
[1] Johns Hopkins Univ, Dept Med, Div Cardiol, Sch Med, 600 N Wolfe St,Carnegie Suite 568, Baltimore, MD 21287 USA
[2] Duke Univ, Dept Med, Div Cardiol, Sch Med, Durham, NC USA
来源:
HEART INTERNATIONAL
|
2021年
/
15卷
/
01期
关键词:
Heart failure;
worsening heart failure;
ambulatory treatment;
outpatient treatment;
remote monitoring;
telemonitoring;
intravenous diuretics;
subcutaneous diuretics;
INTRAVENOUS DIURETIC THERAPY;
SUBCUTANEOUS FUROSEMIDE;
LOOP DIURETICS;
CARE;
COVID-19;
IMPACT;
HOSPITALIZATION;
MORTALITY;
OUTCOMES;
ALGORITHM;
D O I:
10.17925/HI.2021.15.1.49
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Heart failure (HF) is a highly prevalent and morbid disease in the USA. The chronic, progressive course of HF is defined by periodic exacerbations of symptoms, described as 'worsening heart failure' (WHF). Previously, episodes of WHF have required hospitalization for intravenous diuretics; however, recent innovations in care delivery models for patients with HF have allowed a transition from the acute care setting to the ambulatory setting. The development of remote monitoring strategies, including device-based algorithms and implantable haemodynamic monitoring systems, has facilitated more advanced surveillance of patients, aiming to prevent the clinical deterioration that leads to hospitalization. Additionally, the establishment of multidisciplinary HF clinics has provided the setting and resources for the outpatient treatment of WHF, specifically the administration of intravenous diuretics. Here we review the current state of ambulatory HF management, including mechanisms for patient monitoring and treatment, and outline future opportunities for outpatient management of this patient population.
引用
收藏
页码:49 / 53
页数:5
相关论文